Friday, February 24, 2017
 
 
Company News: Page (1) of 1 - 02/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Global Diabetic Foot Infection (DFI) API Manufacturers, Marketed and Phase III Drugs Landscape Report 2017-2018 - Research and Markets

(February 17, 2017)

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Diabetic Foot Infection (DFI) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering.


Diabetic Foot Infection (DFI) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

A key objective of the Diabetic Foot Infection (DFI) Report is to understand the market and pipeline status of the drugs around the Diabetic Foot Infection (DFI) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018.

The Diabetic Foot Infection (DFI) Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Diabetic Foot Infection (DFI).


While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Diabetic Foot Infection (DFI)

7. Phase III Drugs for Diabetic Foot Infection (DFI)

8. Discontinued Drugs for Diabetic Foot Infection (DFI)

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/zln4jd/diabetic_foot


Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs, Endocrine and Metabolic Disorders Drugs


Page: 1


Related Keywords:
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines